Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial

J Jeffrey S. Johnson (Department of Chemistry) J Justin W. Miller F Firas Hatoum M Michael J. Schell X Xiaoqing Yu (Department of Physical Chemistry II) G Gabriel Roman Souza S Sarah Mizelle K Keerthi Gullapalli A Adnan Fazili R Rohit Jain J Jonathan Chatzkel (University of Florida, Gainesville) L Ling Cen J Jasreman Dhillon C Christopher Cubitt J Jiqiang Yao J Junmin Whiting J Jiannong Li J Jennifer Swank G Ghazal Jameel J Jingsong Zhang X Xuefeng Wang (Beijing National Laboratory for Condensed Matter Physics) P Philippe E. Spiess M Mayer Fishman J Jad Chahoud (H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL)